Clinical Trial Update: The Impact of Lorazepam on Cognition in APOE e4 Carriers [NA]

View source ↗

Summary

This completed Mayo Clinic trial examined whether lorazepam affects cognitive function in APOE e4 carriers with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: Mayo Clinic | Conditions: Alzheimer's Disease | NA | Status: COMPLETED